Articles with public access mandates - David S SapersteinLearn more
Not available anywhere: 2
Cryptogenic small‐fiber neuropathies: serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor‐3
TD Levine, J Kafaie, LA Zeidman, DS Saperstein, R Massaquoi, RJ Bland, ...
Muscle & Nerve 61 (4), 512-515, 2020
Mandates: US National Institutes of Health
Phase 2 trial in acetylcholine receptor antibody‐positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study
M Pasnoor, V Bril, T Levine, J Trivedi, NJ Silvestri, M Phadnis, ...
European Journal of Neurology 30 (5), 1417-1424, 2023
Mandates: US National Institutes of Health
Available somewhere: 17
A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis
M Pasnoor, J He, L Herbelin, TM Burns, S Nations, V Bril, AK Wang, ...
Neurology 87 (1), 57-64, 2016
Mandates: US National Institutes of Health
International Guillain‐Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in …
BC Jacobs, B van den Berg, C Verboon, G Chavada, DR Cornblath, ...
Journal of the Peripheral Nervous System 22 (2), 68-76, 2017
Mandates: UK Medical Research Council
Diagnosis of mast cell activation syndrome: a global “consensus-2”
LB Afrin, MB Ackerley, LS Bluestein, JH Brewer, JB Brook, AD Buchanan, ...
Diagnosis 8 (2), 137-152, 2021
Mandates: US National Institutes of Health
Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis
Q Gang, C Bettencourt, PM Machado, S Brady, JL Holton, AM Pittman, ...
Neurobiology of Aging 47, 218. e1-218. e9, 2016
Mandates: Fondazione Telethon, Italy, UK Medical Research Council, National Institute …
Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial
JM Statland, D Moore, Y Wang, M Walsh, T Mozaffar, L Elman, SP Nations, ...
Muscle & nerve 59 (2), 201-207, 2019
Mandates: US National Institutes of Health
A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement
Z Macchi, Y Wang, D Moore, J Katz, D Saperstein, D Walk, E Simpson, ...
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16 (5-6), 345-352, 2015
Mandates: US National Institutes of Health
Patient assisted intervention for neuropathy: comparison of treatment in real life situations (PAIN-CONTRoLS): Bayesian adaptive comparative effectiveness randomized trial
RJ Barohn, B Gajewski, M Pasnoor, A Brown, LL Herbelin, KS Kimminau, ...
JAMA neurology 78 (1), 68-76, 2021
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research Institute
Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy
M Mittal, M Pasnoor, RB Mummaneni, S Khan, A McVey, D Saperstein, ...
International Journal of Neuroscience 121 (9), 521-527, 2011
Mandates: US National Institutes of Health
Review process for IVIg treatment: Lessons learned from INSIGHTS neuropathy study
TD Levine, JS Katz, R Barohn, LJ Vaughan, MM Dimachkie, ...
Neurology: Clinical Practice 8 (5), 429-436, 2018
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research Institute
ALSUntangled No. 30: Methylcobalamin
ALSUntangled Group
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16 (7-8), 536-539, 2015
Mandates: Motor Neurone Disease Association, UK
ALSUntangled no. 16: cannabis
ALSUntangled Group
Amyotrophic Lateral Sclerosis 13 (4), 400-404, 2012
Mandates: Motor Neurone Disease Association, UK
Non‐dystrophic myotonia: 2‐year clinical and patient reported outcomes
TR Fullam, S Chandrashekhar, C Farmakidis, O Jawdat, M Pasnoor, ...
Muscle & nerve 66 (2), 148-158, 2022
Mandates: US National Institutes of Health, UK Medical Research Council, National …
Baseline Characteristics and Outcomes After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With …
IU Scott, NL Oden, PC VanVeldhuisen, MS Ip, BA Blodi, GA Williams, ...
JAMA ophthalmology 140 (5), 458-464, 2022
Mandates: US National Institutes of Health
Cost-utility comparison of bevacizumab and aflibercept in the treatment of central or hemiretinal vein occlusion in the SCORE2 trial
SM Kymes, NL Oden, PC VanVeldhuisen, IU Scott, MS Ip, BA Blodi, ...
JAMA ophthalmology 141 (6), 554-561, 2023
Mandates: US National Institutes of Health
ALSUntangled No. 14: Mototab
ALSUntangled Group
Amyotrophic Lateral Sclerosis 13 (1), 161-164, 2012
Mandates: Motor Neurone Disease Association, UK
Review process for IVIg treatment
MM Dimachkie, DS Saperstein, T Mozaffar, GI Wolfe
Neurology: Clinical Practice 8 (5), 429-436, 2018
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research Institute
Remember the GBS| cidP legacy circle!
GJ Parry, DS Saperstein, KA Sheikh, JS Steinberg, PA van Doorn, ...
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program